23 March 2023 in Equine Veterinary Journal
Background: The sarcoid is the most common equine cutaneous neoplasm. Evidence‐based treatment of this condition is often lacking, and selection of treatment modality based on clinical experience or anecdotal evidence. Objectives: To assess the quality of the currently available best evidence regarding the treatment of the equine sarcoid. Study design: Systematic review. Methods: In compliance with PRISMA guidelines, literature searches were performed in PUBMED, Web of Science, CAB Abstracts, EMBASE (Ovid) and Scopus in April 2021. Included papers were required to describe an interventional study examining sarcoid treatment strategy, of level 4 evidence or greater. The case definition required confirmation of at least some included lesions on histopathology, and a minimum of 6 months of follow‐up was required on treated cases. Studies were assessed by two independent reviewers (KO, CD). Data extraction was performed manually, followed by risk of bias assessment. Methodological quality was assessed using the GRADE system. Results: In total, 10 studies were included in the review. Case definition was confirmed via histopathology in all included lesions in 60% of papers. Time to follow‐up was variably reported. Overall risk of bias ranged from ‘some concerns’ to ‘critical’. Reported sarcoid regression rate ranged from 28% to 100% on an individual sarcoid level, and 9%–100% on a whole horse level. Transient local inflammation was reported following most treatment strategies, with further adverse events reported infrequently. Main limitations: Review methodology excluded a large proportion of available literature regarding the equine sarcoid. Significant heterogeneity between included studies prevented quantitative synthesis and most included papers were at significant risk of bias, indirectness, and imprecision. Conclusions: There is insufficient evidence currently available to recommend one sarcoid treatment over another. There is an urgent need for sufficiently powered, randomised, placebo‐controlled trials in order to allow more definitive comparison of the efficacy of different treatment strategies.
6 May 2021 in Journal of Veterinary Emergency and Critical Care
JFJacob Michael Froehlich
+1
Objective To describe the use of therapeutic plasma exchange (TPE) in the treatment of flunixin meglumine overdose in a cria. Case Summary A 3‐day‐old alpaca cria was diagnosed with ureteral obstruction and agenesis resulting in severe bilateral hydronephrosis. During hospitalization, the cria inadvertently received a flunixin meglumine overdose of >65 mg/kg. Here, we report the use of lipid emulsion and TPE to mitigate flunixin meglumine toxicosis. TPE appeared to prevent any flunixin‐induced kidney or gastrointestinal injury, even in a patient with congenital defects of the urinary tract. New Information Provided This is the first report of the use of TPE in a cria.
9 December 2019 in Equine Veterinary Education
21 May 2022 in Veterinary Record Case Reports
This case report describes suspected myopathy or myelopathy in a 5‐year‐old Clydesdale gelding following general anaesthesia for sarcoid removal. The lowest mean arterial pressure was 67 mmHg. Hyperlactataemia and tachycardia were observed during anaesthesia prompting abortion of surgery. The horse was unable to stand with assistance from a specialised sling. Azotaemia and hyperkalaemia developed in recovery and worsened despite therapeutic interventions. Euthanasia was performed given the grave prognosis. Postmortem examination was not carried out but could have provided a definitive diagnosis. Specific factors have been identified in the prevention of post‐anaesthetic myopathy, including maintenance of adequate tissue perfusion and oxygenation and careful positioning. Potential improvements in the anaesthetic management of this case in relation to these factors are discussed.
23 December 2025 in Journal of Veterinary Medical Education
The script concordance test (SCT) is an assessment method based on script theory, which can be used to assess some components of clinical reasoning. Clinical reasoning is challenging to assess, so the SCT was evaluated as a method of assessing clinical reasoning specifically around equine colic. A SCT was written on equine colic, using an expert panel of 15 equine veterinarians to help develop the test and formulate the scoring. Preclinical veterinary students (year 3 of 5) were recruited to take the SCT, followed by participation in focus groups on clinical reasoning in equine colic and their experience of the SCT. Twenty-four students undertook the SCT, of which 15 participated in focus groups. Final marking of the SCT gave expert panel scores from 27 to 40 out of 43 (mean 34.6 and SD 3.44). The students scored 17–32 (mean 24.9 and SD 4.59). The SCT was liked by the students and they felt the test required them to use clinical reasoning skills related to acute colic.